PTCA Balloon Catheter Market in China 2015-2019
About PTCA balloon catheter
PTCA is a minimally invasive procedure used to remove the blockage of coronary arteries, permitting uninterrupted blood flow to the heart muscle. The procedure involves the placement of a PTCA balloon catheter to compress and clear the blockage caused by plaques and to widen the clogged coronary artery. A PTCA balloon catheter is a soft device equipped with a small inflatable balloon at its tip, which is inserted into an artery during the catheterization procedure. The balloon is then bloated to clear the blockage and widen the artery. PTCA balloon catheter was the first of its kind used in the field of interventional cardiology. It is also used to position stents during angioplasty.
Technavio's analysts forecast the PTCA balloon catheter market in China to grow at a CAGR of 14.75% over the period 2014-2019.
Covered in this report
The report includes the present scenario and the growth prospects of the PTCA balloon catheter market in China for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of PTCA balloon catheters.
Technavio's report, PTCA Balloon Catheter Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Technavio Announces the Publication of its Research Report – PTCA Balloon Catheter Market in China 2015-2019
Technavio recognizes the following companies as the key players in the PTCA Balloon Catheter Market in China: Abbott Laboratories, Boston Scientific Corp., Medtronic plc, MicroPort Scientific Corp. an dTerumo Corp.
Other Prominent Vendors in the market are: Aachen Resonance, Acrostak, AngioScore, Alvimedica, Asahi Intecc, Arthesys, Atrium Medical, B. Braun Melsungen, Biosensors International, BIOTRONIK, Cordis, Cook Medical, C.R. Bard, Goodman, Lepu Medical, Natec Medical, Smiths Medical, Tokai Medical Products and Volcano
Commenting on the report, an analyst from Technavio’s team said: “Physicians and patients are increasingly opting for minimally invasive surgeries in China. Advances in PTCA balloon catheters have led to an increased number of clinical trials and the launch of new products in the market.”
According to the report, the increased workload of the working class, an unhealthy diet, changing lifestyles, and physical inactivity raise blood pressure, blood glucose, and lipids, leading to obesity, hypertension, abnormal cholesterol, and diabetic problems.
Further, the report states that catheter-related bloodstream infections occur in individuals during the insertion of the peripheral catheter into the vein. Bacteria present on the skin are transferred along the catheter track and into the blood lumen, increasing the risk of infection in individuals.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook